Skip to main content
OpenTrials

Clinical trial condition

Polyradiculoneuropathy

Explore clinical trials studying Polyradiculoneuropathy. Study availability and eligibility vary by location and protocol.

168 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Polyradiculoneuropathy trial results

Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

NCT07091630

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +14 more
Locations
  • University of Alabama at Birmingham - 1720 University Blvd Birmingham, Alabama, United States
  • Samir Macwan, M.D., Inc. (S corporation) Rancho Mirage, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • Medstar Health Research Institute Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

NCT07020819

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • St. Joseph's Hospital & Medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • HonorHealth Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • Profound Research LLC Carlsbad, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 13 locations
View Trial Details
Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details

Related conditions